Phase III influenza trial facing critical recruitment delays
Case Study
Site selection & enrollment forecasting for late-stage trial
- Life Sciences
- Current site network projected to miss enrollment targets by 32%
- Trial acceleration essential for maintaining market opportunity
- Need for data-driven site selection to optimise patient recruitment
high-performance sites identified